[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367520-105":59,"doc-detail-367520-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","chaperonin-containing-tcp1-subunit-5-as-a-novel-pan-cancer-prognostic-biomarker-for-tumor-stemness-and-immunotherapy-response","Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response","","Background: Chaperonin containing TCP1 subunit 5 (CCT5), a core molecular chaperonin complex component, is linked to tumorigenesis, cancer stemness, and treatment resistance, yet its pan-cancer mechanisms, biological functions, and ability to predict immunotherapy response remain unclear. Methods: A multi-omics pan-cancer analysis of CCT5 across 33 cancer types integrates bulk RNA-seq, scRNA-seq, and spatial transcriptomics; a CCT5-based machine-learning signature (CCT5.Sig) is trained on 23 ICB cohorts. Results identify prognostic, stemness, and immune microenvironment associations, with improved ICB response prediction.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chaperonin-containing-tcp1-subunit-5-as-a-novel-pan-cancer-prognostic-biomarker-for-tumor-stemness-and-immunotherapy-response/367520/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chaperonin-containing-tcp1-subunit-5-as-a-novel-pan-cancer-prognostic-biomarker-for-tumor-stemness-and-immunotherapy-response/367520.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is CCT5 and why is it studied in cancer immunology?","Question",{"text":112,"@type":113},"CCT5 is a chaperonin complex component involved in tumorigenesis-related processes. It has been implicated in cancer stemness maintenance and therapeutic resistance, motivating investigation of its pan-cancer and immunotherapy-predictive roles.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CCT5 analyzed across cancers?",{"text":117,"@type":113},"The study integrates bulk RNA-seq, single-cell RNA-seq, and spatial transcriptomics across 33 cancer types. It evaluates expression patterns, prognostic relevance, stemness association, and immune microenvironment relationships.",{"name":119,"@type":110,"acceptedAnswer":120},"What is CCT5.Sig and how does it perform for immunotherapy response prediction?",{"text":121,"@type":113},"CCT5.Sig is a machine-learning signature derived from genes co-expressed with CCT5. It predicts immune checkpoint blockade (ICB) response with AUC values of 0.82 in validation and 0.76 in independent testing, outperforming existing pan-cancer signatures.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367520,1790198350,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Immunology, Immunotherapy (2025) 74:224 [https://doi.org/10.1007/s00262-025-04071-7](https://doi.org/10.1007/s00262-025-04071-7)  \nChaperonin containing TCP1 subunit 5 as a novel pan‑cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi‑omics data, integrated machine learning, and experimental validation  \nJiajun Li1,2 · Nuo Xu2 · Leyin Hu4 · Jiayue Xu1 · Yifan Huang1 · Deqi Wang3 · Feng Chen1 · Yi Wang3 · Jiani Jiang3 · Yanggang Hong1 · Huajun Ye3  \nReceived: 23 March 2025 / Accepted: 28 April 2025 / Published online: 27 May 2025 © The Author(s) 2025  \nAbstract  \nBackground Chaperonin containing TCP1 subunit 5 (CCT5), a vital component of the molecular chaperonin complex, has been implicated in tumorigenesis, cancer stemness maintenance, and therapeutic resistance. Nevertheless, its comprehensive roles in pan-cancer progression, underlying biological functions, and potential as a predictor of immunotherapy response remains poorly understood.  \nMethods We performed a comprehensive multi-omics pan-cancer analysis of CCT5 across 33 cancer types, integrating bulk RNA-seq, single-cell RNA-seq (scRNA-seq), and spatial transcriptomics data. CCT5 expression patterns, prognostic relevance, stemness association, and immune microenvironment relationships were evaluated. A novel CCT5-based signature (CCT5.Sig) was developed using machine learning on 23 immune checkpoint blockade (ICB) cohorts (n = 1394) spanning eight cancer types. Model performance was assessed using AUC metrics and survival analyses.  \nResults CCT5 was significantly overexpressed in tumor tissues and primarily localized to malignant and cycling cells. High CCT5 expression correlated with poor prognosis in multiple cancers and was enriched in oncogenic, cell cycle, and DNA damage repair pathways. CCT5 expression was positively associated with mRNAsi, mDNAsi, and CytoTRACE scores, indicating a role in stemness maintenance. Furthermore, CCT5-high tumors exhibited immune-cold phenotypes, with reduced TILs and CD8⁺ T cell activity. The CCT5 .Sig model, based on genes co-expressed with CCT5, achieved superior predictive accuracy for ICB response (AUC = 0.82 in validation and 0.76 in independent testing), outperforming existing pan-cancer signatures.  \nJiajun Li, Nuo Xu, Leyin Hu, Jiayue Xu and Yifan Huang contributed equally to this work.  \n* Yanggang Hong [sun160414@icloud.com](sun160414@icloud.com)  \n* Huajun Ye[yehuajun2020@163.com](yehuajun2020@163.com)  \n1 The Second School of Clinical Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang, China  \n2 State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute and Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China  \n3 Department of Gastroenterology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, Zhejiang, China  \n4 Department of Pathology, Zhejiang Cancer Hospital, Hangzhou 305000, Zhejiang, China  \nConclusion This study reveals the multifaceted oncogenic roles of CCT5 and highlights its potential as a pan-cancer biomarker for prognosis and immunotherapy response. The machine learning-derived CCT5.Sig model provides a robust tool for patient stratification and may inform personalized immunotherapy strategies.  \nGraphical abstract  \nKeywords CCT5 · Pan-cancer · Cancer stemness · Tumor microenvironment · Immune checkpoint blockade · Single-cell analysis · Machine learning  \nIntroduction  \nCancer is a leading cause of death globally. According to Global Cancer Statistics 2022, GLOBOCAN estimates suggest that approximately one in five men or women  \ndevelop cancer during their lifetime, whereas approximately one in nine men and one in 12 women would die from it [1] . Conventional therapy methods, including surgical resection, chemotherapy, radiotherapy, hormone therapy, and immunotherapy based on immune checkpoint  \nblockade (ICB), have revolutionized the tr","cbCaitfkVGH2YGaW","https://ap.wps.com/l/cbCaitfkVGH2YGaW","pdf",19117443,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is CCT5 and why is it studied in cancer immunology?\",\"answer\":\"CCT5 is a chaperonin complex component involved in tumorigenesis-related processes. It has been implicated in cancer stemness maintenance and therapeutic resistance, motivating investigation of its pan-cancer and immunotherapy-predictive roles.\"},{\"question\":\"How was CCT5 analyzed across cancers?\",\"answer\":\"The study integrates bulk RNA-seq, single-cell RNA-seq, and spatial transcriptomics across 33 cancer types. It evaluates expression patterns, prognostic relevance, stemness association, and immune microenvironment relationships.\"},{\"question\":\"What is CCT5.Sig and how does it perform for immunotherapy response prediction?\",\"answer\":\"CCT5.Sig is a machine-learning signature derived from genes co-expressed with CCT5. It predicts immune checkpoint blockade (ICB) response with AUC values of 0.82 in validation and 0.76 in independent testing, outperforming existing pan-cancer signatures.\"}]","Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response | PDF",1790171176,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25878028e7dac6d0e5f44b25e06888dc.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbba897550f8f4696907173d52e8a627.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98d9794e728f10084097130870ac266f.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06c8dd62db0ec7cd68d0c9e3cd87a1f5.webp",980,1301]